$5, 15 minutes out... Abbott's portable new crown detection card is authorized by the FDA for emergency use.

BinaxNOW is used to qualitatively detect new coronavirus-specific antigens in the nasal cavity.
based on Abbott's side-flow detection technology and needs to be used by medical professionals.
medical staff used a simple nasal swab to collect samples of patients suspected of being infected with the new coronavirus and then put the samples directly into the BinaxNOW test card.
BinaxNOW test card can give positive or negative results like a pregnancy test stick.
data submitted to the FDA, BinaxNOW tested 97.1 percent sensitivity and 98.5 percent specificity in patients with suspected COVID-19 during the first seven days of symptom attacks.
photo source: Reference : BinaxNOW is expected to serve as a bedside test as a first line of defense to identify current infections and patients who should be quarantined to help prevent the spread of the disease.
plans to ship tens of millions of tests in September and increase the testing capacity to 50 million a month by early October.
, Abbott will also launch a free app for use on iPhones and Android devices.
the app, called NAVAA, is free to use and allows people with negative test results to display a temporary digital health pass, which is updated with the date of the test results each time it is tested.
organizations will be able to view and verify information on mobile devices, together with public health measures such as hand washing, maintaining social distance, enhancing cleaning and wearing masks, to help people return to normal life.
photo source: Resources: s1' Abbott's Fast, $5, 15-Minute, Easy-to-Use COVID-19 Antigen Test Receives FDA Emergency Use Authorization; Mobile App Displays Test Results to Help Our Return to Daily Life; Ramping Production to 50 Million Tests a Month. Retrieved August 27, 2020, from.